The Acarbose Cardiovascular Evaluation (ACE) trial was a randomised, double-blind, placebo-controlled, phase 4 trial, with patients recruited from 176 hospital outpatient
The US regulatory authorities have approved Bayer's Precose (acarbose), an alpha glucosidase inhibitor, for the management of patients with Type II (non-insulin
Acarbose is taken with meals to slow
DATA SYNTHESIS: Acarbose is effective in reducing postprandial hyperglycemia
A fixed dose combination product comprising acarbose and metformin for the treatment of type-2 diabetes mellitus is being developed by Bayer Healthcare
, Ltd
Learn how to use it with a low carb diet
Sometimes, researchers continue studying a treatment after it has been approved to learn more about how doctors decide which treatment to give to patients
10 Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
The history of acarbose begins with the screening program initiated by Bayer AG of various Acarbose (Oral Route) Drug information provided by: Merative, Micromedex
1975)
Acarbose is a competitive inhibitor of intestinal alpha-glucosidases with maximum specific inhibitory activity against sucrase
The Bayer US Patient Assistance Foundation is a charitable organization that helps eligible patients get their Bayer prescription medicine at no cost
Procedure no
not available
SAFETY DATA SHEET Creation Date 12-May-2015 Revision Date 28-Dec-2021 Revision Number 4 1
Kết quả là glucose máu tăng chậm hơn sau khi ăn, giảm nguy cơ tăng glucose máu, và nồng độ glucose máu ban ngày dao động Acarbose is a complex oligosaccharide that acts as an inhibitor of several enzymes responsible for the breakdown of complex carbohydrates in the intestines
(2009) ed
2008-01-30: Not applicable: US: Precose: Tablet: Acarbose is a commonly used medication for managing type 2 diabetes mellitus
Pine Brook
It is available in tablet formation for oral use in the treatment of type 2 diabetes mellitus in humans
Protect from moisture